| Literature DB >> 35723827 |
Afaf Girgis1,2, Adeola Bamgboje-Ayodele3,4,5, Orlando Rincones4, Shalini K Vinod3,4,6, Sandra Avery4,6,7,8, Joseph Descallar3,4, Allan 'Ben' Smith3,4, Belinda Arnold9, Anthony Arnold9, Victoria Bray3,4,6, Ivana Durcinoska4, Nicole M Rankin10, Geoff P Delaney3,4,6.
Abstract
BACKGROUND: To realize the broader benefits of electronic patient-reported outcome measures (ePROMs) in routine care, we used the RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) framework to inform the translation of a clinically effective ePROM system (hereafter referred to as the PRM system) into practice. The study aimed to evaluate the processes and success of implementing the PRM system in the routine care of patients diagnosed with lung cancer.Entities:
Year: 2022 PMID: 35723827 PMCID: PMC9207870 DOI: 10.1186/s41687-022-00475-6
Source DB: PubMed Journal: J Patient Rep Outcomes ISSN: 2509-8020
Components of RE-AIM evaluation framework
| Constructs and definitions applied for this study | Questions addressed | Data sources used (# aligns with the # for each question addressed) | Timepoint |
|---|---|---|---|
| 1. What is the number and proportion of patients in clinic | 1. Clinical audit log completed over a 3-month period | Baseline (pre-implementation) | |
| The number, proportion and representativeness of people who attend lung cancer clinic | (a) with internet/mobile phone access at home | ||
| (b) capable of completing assessment in English vs other native language | |||
| (c) who require assistance to complete assessments | |||
| (d) who prefer to complete PROs on paper vs electronic device? | |||
| 2. What is the number and proportion of patients completing assessment screening including the number and proportion of those systemically missed and why? | 2. Oncology Information System (OIS)—MOSAIQ records | At first assessment timepoint in clinic | |
| Compared to a historical control cohort: | 1. Electronic medical records (eMR) | Historical control and throughout implementation period | |
| The effectiveness of ePROs in improving lung cancer care | 1. What is the impact of ePROs on the number of admissions to hospital due to ED presentations? | ||
| 2. What is the impact of ePROs on the use of the cancer assessment unit? | |||
| 3. What is the impact of ePROs on care coordinator referral rates? | 2 and 3. OIS (MOSAIQ) records | ||
| 1. What is the extent to which the new model of care and implementation strategies are considered feasible and appropriate among HCPs, given the different needs and resources of each hospital? | 1 and 2. Organizational readiness for implementing change (ORIC) survey | Baseline and at 5-months | |
| The development of organizational support to deliver ePROs | |||
| 2. What is the number, proportion and representation of HCP (change agents) implementing ePROs? | 1 and 2. ePROM HCP Survey | Baseline and at 5-months | |
| 3. What is the number and proportion of all cancer services staff completing ePROM orientation? | 1. Field notes and recordings of HCP feedback during MDT meetings and workshops | Throughout implementation period | |
| 2 and 3. Orientation attendance logs | |||
| 1. What is the number and proportion of patients screened at each hospital? | 1 and 2. OIS (MOSAIQ) records | Throughout implementation period | |
| The extent of ePROM implementation at each hospital. i.e. the degree to which each hospital receives the planned implementation strategies, and success of implementation processes | |||
| 2. What is the number and proportion of clinical alerts actioned or followed up by HCP? | |||
| 3. What is number of HCPs receiving orientation and implementation resources? | 3. Orientation attendance logs | ||
| 3. PROMs website views | |||
| 1. What is the number and proportion of staff who maintain ePROM engagement over a 5-month implementation? | 1. HCP survey (baseline and follow-up) | Baseline and follow-up | |
| Incorporating ePROs in routine care to ensure sustainability over time | |||
| 2. What is staff feedback on ePROs implementation in routine clinical practice? | 1. OIS (MOSAIQ) records | Throughout implementation period | |
| 2. Interviews with HCP and field notes | Post-implementation |
Fig. 1Study diagram
Characteristics of onboarded patients
| Characteristics | Values |
|---|---|
| Age (years), mean (SD) [Range] | 69 (9) [42–85] |
| Sex | n (%) |
| Male | 29 (60.4) |
| Female | 19 (39.6) |
| Stage of disease | |
| I | 4 (8.3) |
| II | 5 (10.4) |
| III | 11 (22.9) |
| IV | 24 (50) |
| Unknown | 4 (8.3) |
| Treatment received | |
| Chemotherapy* | 37 (77) |
| Radiotherapy* | 35 (72.9) |
| Surgery | 7 (14.6) |
| Immunotherapy* | 19 (39.6) |
Note 1: patients received multiple treatments
*Started treatments; most were completed after the trial period end date 15/04/2021
Referrals to allied health services in the PRM group
| Allied health service ∞ | Total number of referrals | Accepted n (%**) | Offered, but declined n (%**) |
|---|---|---|---|
| Social work | 37 | 24 (64.9) | 13 (35.1) |
| Dietetics | 27 | 13 (48.1) | 14 (51.9) |
| Physiotherapy | 27 | 7 (26) | 20 (74) |
| Occupational therapy | 25 | 4 (16) | 21 (84) |
| Clinical psychology | 21 | 5 (23.8) | 16 (76.2) |
| Palliative care | 5 | 4 (80) | 1 (20) |
| Lymphoedema clinic | 2 | 2 (100) | – |
| Transport | 1 | – | 1 (100) |
| Home care | 1 | – | 1 (100) |
| Total | 146 | 59 (40.4) | 87 (59.6) |
**Based on the total of referrals within each category
∞Multiple referrals can be made/attempted after a breach in a single action/phone call
Demographic characteristics of baseline ORIC and HCP survey respondents
| Characteristic | ORIC (n = 37) | HCP (n = 21) |
|---|---|---|
| Gender (%) | ||
| Female | 32 (86.5) | 19 (90.5) |
| Male | 5 (13.5) | 2 (9.5) |
| Hospital (%) | ||
| Hospital #1 | 26 (70.3) | 11 (52.4) |
| Hospital #2 | 8 (21.6) | 7 (33.3) |
| Hospital #3 | 3 (8.1) | 3 (14.3) |
| Area of work (%) | ||
| Allied health | 13 (35.1) | 13 (61.9) |
| Administration | 12 (32.4) | NA |
| Cancer care coordination | 6 (16.2) | 6 (28.6) |
| Nursing | 2 (5.4) | 2 (9.5) |
| Management | 2 (5.4) | NA |
| Other | 1 (2.7) | NA |
Staff quotes regarding the PRMs system
| A | |
| B | “ |
| C | |
| D | |
| E | |
| F | |
| G | “ |
| H | |
| I |